300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Zimbabwe
Zambia
Norway
Tajikistan
Oman
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
China
Armenia
Costa Rica
Kuwait
Czech Republic
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Austria
Ethiopia
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Belize
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in Israel (August 2026)

The most active venture capital funds investing in Israel Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Israel Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
OurCrowd
VC Fund
12 Israel, United States, New Zealand Series B, Series A, Seed Software, Artificial Intelligence, Health Care $593k–$65M
Pontifax
VC Fund
10 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $6.3M–$130M
Trendlines Group
VC Fund
8 Israel, Singapore, United Kingdom Seed, Series A Health Care, Biotechnology, Medical Device $650k–$15M
Israel Innovation Authority
VC Fund
8 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Artificial Intelligence, Biotechnology $130k–$5M
HBL Hadasit Bio Holdings
VC Fund
5 Israel Seed, Series A Biotechnology, Medical, Health Care
aMoon Fund
VC Fund
4 United States, Israel, France Series B, Series A, Series C Health Care, Biotechnology, Medical $5.7M–$93M
Btomorrow Ventures
VC Fund
4 United States, United Kingdom, India Series A, Seed, Series B Health Care, Wellness, Food and Beverage
Triventures
VC Fund
4 United States, Israel, Ireland Series A, Series B Health Care, Medical Device, Medical $6M–$28M
Vertex Ventures Israel
VC Fund
4 Israel, United States, Canada Series A, Series B, Series C Software, Information Technology, Artificial Intelligence $3.5M–$100M
S2G Investments
VC Fund
4 United States, Canada, Israel Series A, Series B, Series C Food and Beverage, Agriculture, Biotechnology $3.9M–$100M
Agriline
VC Fund
4 Israel Seed, Series A, Venture - Series Unknown Health Care, Medical, Medical Device $1.3M–$17M
XTX Ventures
VC Fund
3 United Kingdom, United States, Israel Series A, Seed Artificial Intelligence, Software, Machine Learning $2M–$60M
Insight Partners
VC Fund
3 United States, Israel, Germany Series B, Series A, Series C Software, Information Technology, SaaS $12M–$150M
MTIP AG
VC Fund
3 United States, United Kingdom, Spain Series A, Series B, Series C Health Care, Medical, Artificial Intelligence $1.5M–$80M
Tal Ventures
VC Fund
3 Israel, United States, Cyprus Seed, Series A, Pre-Seed Software, Artificial Intelligence, SaaS $2.1M–$25M
Technion - Israel Institute of Technology
VC Fund
3 Israel, United States Seed, Series B, Venture - Series Unknown Medical, Health Care, Therapeutics $2.2M–$20M
Ziegler Meditech Equity Partners
VC Fund
3 United States, Israel Series C, Series E, Series F Health Care, Biotechnology, Mobile
Connecticut Innovations
VC Fund
3 United States, Israel, Canada Seed, Series A Health Care, Biotechnology, Software $300k–$25M
CE Ventures (CEIIF)
VC Fund
3 Israel, United States, India Series B, Series A, Series C Software, Analytics, Big Data $4M–$40M
Docor International Management
VC Fund
3 Israel, United States Series C, Series A Health Care, Biotechnology, 3D Technology $13M–$22M
Entrée Capital
VC Fund
3 United States, Israel, United Kingdom Seed, Series A, Series B Software, FinTech, Financial Services $1.5M–$60M
Alumni Ventures
VC Fund
3 United States, United Kingdom, Canada Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.5M–$79M
Good Company
VC Fund
3 Israel, United States Seed, Pre-Seed, Series A Software, Artificial Intelligence, Recruiting $400k–$22M
Terra Venture Partners
VC Fund
3 Israel, United States Seed, Series A, Series B Software, Machine Learning, Artificial Intelligence $1M–$30M
Robin Hood Ventures
VC Fund
3 United States, Canada, Israel Seed, Series A Software, Health Care, Biotechnology $100k–$11M
ALIVE Israel HealthTech Fund
VC Fund
3 Israel, United States Series A, Series C, Series B Health Care, Medical, Medical Device $4.4M–$55M
Neo Ventures
VC Fund
3 United States, United Kingdom, Israel Seed, Series A Software, Artificial Intelligence, SaaS $500k–$24M
Accelmed
VC Fund
2 United States, Israel Series D, Series A Health Care, Medical Device, Medical $695k–$96M
Angular Ventures
VC Fund
2 Israel, United States, United Kingdom Seed, Pre-Seed, Series A Software, SaaS, Artificial Intelligence $1.2M–$45M
Elron Ventures
VC Fund
2 Israel, United States, China Seed, Series A Information Technology, Software, Cyber Security $1M–$17M
Arkin Holdings
VC Fund
2 Israel, United States, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Medical $2M–$95M
Shalom Equity Fund
VC Fund
2 Israel Seed Medical, Sensor, Health Care
SCP Vitalife Partners
VC Fund
2 Israel, United States Series C, Series D Health Care, Medical, Medical Device $1.2M–$43M
Vertex Ventures
VC Fund
2 United States, China, Israel Series A, Series B, Series C Software, Information Technology, Artificial Intelligence $3M–$100M
OrbiMed
VC Fund
2 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$183M
fresh.fund
VC Fund
2 Israel, United States, Norway Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $300k–$21M
LionBird
VC Fund
2 United States, Israel, India Seed, Series A, Series B Health Care, Software, Artificial Intelligence $1.3M–$40M
TechWald Holding S.p.A.
VC Fund
2 Israel, United States, Switzerland Series A, Series B, Series C Health Care, Medical Device, Medical $3.6M–$60M
DEFTA Partners
VC Fund
2 United States, Israel, Japan Series A, Series B Biotechnology, Medical, Health Care $2.5M–$47M
Grove Ventures
VC Fund
2 Israel, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $3.5M–$74M
ZORA Ventures
VC Fund
2 Israel, United States, United Kingdom Seed, Series A, Convertible Note Biotechnology, Health Care, Food and Beverage $1M–$8.6M
Hanaco Venture Capital
VC Fund
2 United States, Israel, United Kingdom Series A, Seed, Series B Software, FinTech, Financial Services $3M–$56M
Mithril Capital Management
VC Fund
2 United States, United Kingdom, Israel Series C, Series B, Series D Software, Health Care, Enterprise Software $10M–$300M
HealthpointCapital
VC Fund
2 Israel, United States Series B, Series C Medical, Biotechnology, Manufacturing $5M–$15M
Israel Healthcare Ventures
VC Fund
2 Israel, United States Series D, Series F Health Care, Medical Device, Medical $1.2M–$40M
Eclipse
VC Fund
2 United States, Canada, Israel Series A, Series B, Seed Software, Robotics, Artificial Intelligence $2.3M–$100M
Mindset Ventures
VC Fund
2 United States, Israel, Canada Series A, Seed, Series B Software, Artificial Intelligence, Machine Learning $2.3M–$35M
Qure Ventures
VC Fund
2 United States, Israel Series A, Series B, Series C Health Care, Medical Device, Medical $11M–$20M
Lightspeed Venture Partners
VC Fund
2 United States, India, Israel Series A, Series B, Seed Software, Information Technology, Artificial Intelligence $2.5M–$125M
GlenRock Israel
VC Fund
2 Israel, United States Seed, Series A, Series B Software, Health Care, Cyber Security $100k–$30M
Access all 522 VC funds in Israel Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

OurCrowd
VC Fund · Jerusalem, Yerushalayim, Israel · 12 investments in Israel Medical startups

Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: Israel, United States, New Zealand

Investor stats

  • Total investments: 309
  • Round size: Seed $593k–$10M; Series A $5.3M–$34M; Series B $8M–$65M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
  • Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
  • MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 10 investments in Israel Medical startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 117
  • Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $12M–$101M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
  • Otic Pharma — Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing anasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 8 investments in Israel Medical startups

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A
  • Geography: Israel, Singapore, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Seed $650k–$4.1M; Series A $2.3M–$15M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 8 investments in Israel Medical startups

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Biotechnology
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 200
  • Round size: Seed $500k–$5M; Grant $130k–$3.5M; Pre-Seed $150k–$2.1M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
  • NanoGhosts — NanoGhosts’ technology is based on its founder’s research, that the Technion's commercial unit has patented in the U.S. and Europe.
  • GeoRank Studio — Get your business ranked on Google, cited by ChatGPT & Perplexity, and protected from reputation damage. Specialist SEO and GEO agency. Free consultation.
Show all investments...

HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel · 5 investments in Israel Medical startups

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 11
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show all investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel · 4 investments in Israel Medical startups, 6 in the past 12 months

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 79
  • Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
  • Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
  • Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
Show all investments...

Btomorrow Ventures
VC Fund · London, England, United Kingdom · 4 investments in Israel Medical startups, 6 in the past 12 months

Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 44
  • Lead/follow: no public data

Portfolio highlights

  • Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
  • Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
  • PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Show all investments...

Triventures
VC Fund · Herzliya, Tel Aviv, Israel · 4 investments in Israel Medical startups

Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B
  • Geography: United States, Israel, Ireland

Investor stats

  • Total investments: 60
  • Round size: Series A $6M–$24M; Series B $6M–$28M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
  • Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
  • TailorMed — Moving Mountains for Patients
Show all investments...

Vertex Ventures Israel
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Israel Medical startups

We partner early with global-minded entrepreneurs seeking to disrupt large markets

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States, Canada

Investor stats

  • Total investments: 184
  • Round size: Series A $3.5M–$28M; Series B $4.7M–$35M; Series C $5.6M–$100M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $70M in 2018

Portfolio highlights

  • Rylo — Nagish captions your phone calls and empowers you to talk using text or voice. It's fast, private, and free.
  • Aternity — Unlocking the full potential of your digital experiences has never been more accessible. Illuminate, accelerate and fully leverage the full breadth of possibilities with Riverbed.
  • Quantum Art — Quantum Art develops scalable, multi-core quantum computers with advanced trapped ion qubits and multi-qubit gates, accelerating breakthroughs in AI, finance, and materials science.
Show all investments...

S2G Investments
VC Fund · Chicago, Illinois, United States · 4 investments in Israel Medical startups

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Show more...

Investment focus

  • Industry: Food and Beverage, Agriculture, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 215
  • Round size: Series A $4M–$50M; Series B $3.9M–$100M; Series C $9.4M–$92M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Atomo Coffee — Atomo Coffee is a developer of molecular coffee. Atomo has reverse-engineered the coffee bean to create a smooth cup of coffee, made of naturally derived ingredients, and more sustainable than current commercial coffee.
  • SWARM — SWARM is a Software-as-a-Service platform that uses a next generation cognitive computing system, structured around a multi-agent approach which can utilize a cur
  • Kuehnle Agrosystems — Kuehnle AgroSystems curates a unique set of algae originating from pristine waters and ecosystems of Hawaii, as well as tropical botanical accessions representing plants prized by Polynesian voyagers.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Agriline
VC Fund · Bromsgrove, Worcestershire, United Kingdom · 4 investments in Israel Medical startups

Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Show all investments...

XTX Ventures
VC Fund · London, England, United Kingdom · 3 investments in Israel Medical startups

XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 96
  • Round size: Seed $2M–$7.6M; Series A $6M–$60M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Jenesys AI — Meet Jack, your AI-powered bookkeeping agent, automates line-item extraction, GL coding, and bank reconciliation with real-time insights.
  • Qureight — Pioneering data curation to solve complex diseases
  • Proxima Fusion — We are a European fusion energy startup pursuing the clearest path to grid deployment.
Show all investments...

Insight Partners
VC Fund · New York, New York, United States · 3 investments in Israel Medical startups

Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, Germany

Investor stats

  • Total investments: 1212
  • Round size: Series A $12M–$70M; Series B $20M–$115M; Series C $27M–$150M
  • Lead/follow: 66% lead, 34% follow
  • Last fund: May invest from a new fund soon — raised $3.3B in 2015

Portfolio highlights

  • Trustible AI — Document, manage, and report on your AI Governance strategy to build trust and reduce risk. https://www.trustible.ai/
  • Pluralsight — Pluralsight is the technology workforce development company that helps teams know more and work better together with stronger skills, improved processes and informed leaders.
  • commercetools — We are the world's leading commerce platform built on modern commerce principles. Start now for free.
Show all investments...

MTIP AG
VC Fund · Basel, Basel-Stadt, Switzerland · 3 investments in Israel Medical startups

MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!

Show more...

Investment focus

  • Industry: Health Care, Medical, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Spain

Investor stats

  • Total investments: 28
  • Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: Likely still investing — raised $250M in 2021

Portfolio highlights

  • TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
  • Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
  • NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Show all investments...

Tal Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Israel, United States, Cyprus

Investor stats

  • Total investments: 59
  • Round size: Seed $3M–$12M; Pre-Seed $2.1M–$4M; Series A $5M–$25M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
  • Yuki — Reduce warehouse waste, prevent budget spikes, and keep queries fast across Snowflake and BigQuery. Yuki keeps AI workloads under control with budgets and priorities built in, optimizing in real time with zero engineer effort.
  • Majestic Labs ai — Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.
Show all investments...

Technion - Israel Institute of Technology
VC Fund · Haifa, Hefa, Israel · 3 investments in Israel Medical startups

“Technikum” - the original German name of the Technion - is a tale of the century. The second industrial revolution created the printing presses and communications infrastructure allowing Jews scattered across the globe to organize in face of rising anti-Semitism. As Jews were often barred from technical education, the establishment of a technicalschool was a first priority to rebuilding a Jewish homeland. The Technion was to become unique worldwide as a university that would precede, create, shape, and protect a modern state.The cornerstone laid on April 11, 1912, set in motion a century of progress responding to national and global needs. Technion would grow rapidly, becoming a global pioneer in fields such as biotechnology, stem cells, space, computer science, nanotechnology, and energy. Three Technion professors have won Nobel Prizes. As it celebrates its cornerstone centennial in 2012, Technion City is a thriving world center of research and teaching, with 12,850 students and 80 graduate programs trailblazing excellence in research and teaching for the benefit of humanity.

Show more...

Investment focus

  • Industry: Medical, Health Care, Therapeutics
  • Stage:Seed, Series B, Venture - Series Unknown
  • Geography: Israel, United States

Investor stats

  • Total investments: 5
  • Round size: Seed $2.2M–$20M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mana.bio — Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
  • ViAqua Therapeutics — ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.
  • Levron Medical — Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients.
Show all investments...

Ziegler Meditech Equity Partners
VC Fund · Milwaukee, Wisconsin, United States · 3 investments in Israel Medical startups

Ziegler is a privately held investment bank, capital markets and proprietary investments firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Mobile
  • Stage:Series C, Series E, Series F
  • Geography: United States, Israel

Investor stats

  • Total investments: 6
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
  • MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
  • MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Show all investments...

Connecticut Innovations
VC Fund · Rocky Hill, Connecticut, United States · 3 investments in Israel Medical startups

At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 267
  • Round size: Seed $300k–$6M; Series A $2.4M–$25M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $50M in 2023

Portfolio highlights

  • eBrevia — Analyze contracts at scale, extract key data, and identify risk with eBrevia. Draft and redline agreements in Microsoft Word with DraftPro.
  • Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
  • LegiTime Technologies — LegiTime Technologies, Inc. provides LegiText, a subscription-based SMS solution that offers message authentication, categorization, and archiving based on demonstration of legitimacy technology. It also provides LegiTrac that locates and tracks devices, as well as back up and stores data in a central location; and LegiAlert that offers messagebroadcasts and alerts, creates groups and contact lists, and integrates contact information with existing back office data systems. The company serves enterprises and educational institutions, as well as consumer, finance and banking, and healthcare industries. LegiTime Technologies, Inc. was founded in 2005 and is based in Farmington, Connecticut.
Show all investments...

CE Ventures (CEIIF)
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 3 investments in Israel Medical startups

CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.

Show more...

Investment focus

  • Industry: Software, Analytics, Big Data
  • Stage:Series B, Series A, Series C
  • Geography: Israel, United States, India

Investor stats

  • Total investments: 34
  • Round size: Series A $4M–$7M; Series B $4M–$30M; Series C $10M–$40M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
  • NirogStreet — NirogStreet is the best platform for Ayurveda doctors. Learn and Earn from top Ayurveda Experts and get authentic Ayurvedic medicines at the best deals.
  • Centrical — Centrical helps businesses improve employee engagement, proficiency, and performance through gamification, microlearning, and performance management.
Show all investments...

Docor International Management
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, 3D Technology
  • Stage:Series C, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Series C $13M–$22M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
  • Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Entrée Capital
VC Fund · London, England, United Kingdom · 3 investments in Israel Medical startups

We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 278
  • Round size: Seed $1.5M–$15M; Series A $5M–$30M; Series B $14M–$60M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $300M in 2022

Portfolio highlights

  • Classiq Technologies — A software platform that helps users create scalable complex quantum computer algorithms, software, and circuits for any gate-based quantum computer
  • Identiq — Identiq's network members fight fraud and improve user experience by validating new users and vouching for ones they already know without sharing any personal user data at all.
  • IRP Systems — IRP Systems delivers high performance electric vehicle systems, EVVER e-powertrains and TrueDRIVE control software for fast integration.
Show all investments...

Alumni Ventures
VC Fund · Manchester, New Hampshire, United States · 3 investments in Israel Medical startups

Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 2214
  • Round size: Seed $1.5M–$10M; Series A $5.5M–$35M; Series B $12M–$79M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • WINN.AI — WINN.AI helps revenue teams run better sales calls and win more deals by automating admin work and guiding reps live, during the call.
  • Car Body Lab — The easy way, online.
  • Perennial — Cloud Agronomics is the platform for soil carbon management.
Show all investments...

Good Company
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

Good Company Fund is investing in early-stage companies that leverage deep technologies to solve the world’s biggest problems. The firm is constantly seeking bold entrepreneurs who are building frontier technology solutions. Good Company Fund is generally looking to invest in innovative, hyper scalable, software solutions. It is especially excitedabout: Future of Energy, Future of Work and Education, Future of Work, Circular Economy, Precision Farming, and Digital Health. However, it is constantly learning and looking for additional opportunities in other verticals and aiming to invest in the "Operating System of the New, Sustainable World".Good Company's studio brings together multinational corporations, entrepreneurs and capital, in order to solve the world’s biggest problems. Good Company Studio is a home for entrepreneurs who want to create businesses with a purpose. The Studio is a pre-seed platform that provides entrepreneurs with capital, network, go-to-market, mentoring, and support.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Recruiting
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $700k–$22M; Pre-Seed $400k–$4.8M; Series A $5M–$17M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Jotit — Jotit is a cutting-edge educational technology startup that uses handwriting tools to help kids, instructors, and parents stay organized.
  • TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
  • Algocell — Optimize precision fermentation and cell culture bioprocesses using Digital Twin, AI and Hybrid Models. Create your first model now!
Show all investments...

Terra Venture Partners
VC Fund · Jerusalem, Yerushalayim, Israel · 3 investments in Israel Medical startups

We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies

Show more...

Investment focus

  • Industry: Software, Machine Learning, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 41
  • Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2013

Portfolio highlights

  • ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
  • Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
  • Intuition Robotics — The AI care companion robot for older adults
Show all investments...

Robin Hood Ventures
VC Fund · Philadelphia, Pennsylvania, United States · 3 investments in Israel Medical startups

Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 161
  • Round size: Seed $210k–$4.3M; Series A $100k–$11M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Aseon Labs — Robotic pitstops for self driving cars. A depot in a box for charging, cleaning & inspecting AVs directly in operating zones. Backed by @ycombinator
  • Cooler Heads — Cooler Heads develops cold caps designed for chemotherapy patients.
  • Surface Design Solutions — Surface Design Solutions uses physics-informed AI to help manufacturers reduce scrap, improve yield, and diagnose costly surface performance issues.
Show all investments...

ALIVE Israel HealthTech Fund
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series C, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 15
  • Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Show all investments...

Neo Ventures
VC Fund · Sofia, Grad Sofiya, Bulgaria · 3 investments in Israel Medical startups

Neo Ventures is a venture capital investment platform focused on deep tech, funds and high-growth startup portfolio.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 18
  • Round size: Seed $500k–$2.9M; Series A $2.3M–$24M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Bulbi — Bulbi is a child development platform designed to help parents discover online and face-to-face educational activities for their children.
  • Convex — All gas, no breakages. Convex is the reactive backend platform that keeps up with you and your agents.
  • Extend Robotics — Extend Human Capabilities Beyond Physical Presence
Show all investments...

Accelmed
VC Fund · Aventura, Florida, United States · 2 investments in Israel Medical startups

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series D, Series A
  • Geography: United States, Israel

Investor stats

  • Total investments: 41
  • Round size: Series A $695k–$24M; Series D $13M–$96M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
  • UltraClear — UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
  • GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Show all investments...

Angular Ventures
VC Fund · London, England, United Kingdom · 2 investments in Israel Medical startups, 9 in the past 12 months

Angular Ventures is a specialist venture capital firm committed to founders redefining global markets.

Show more...

Investment focus

  • Industry: Software, SaaS, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 74
  • Round size: Seed $2.3M–$8M; Pre-Seed $1.2M–$3.1M; Series A $7M–$45M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Medida AI — Medida is an AI virtual measuring system that provides accurate digitized measurements for home renovation companies.
  • Reco — SaaS Security Leverage Reco's context analysis to streamline SaaS security, minimize data and identity risk, and automate remediation
  • groundcover — Instantly pinpoint bleeding issues in production & troubleshoot quickly with groundcover. All with zero code changes.
Show all investments...

Elron Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.

Show more...

Investment focus

  • Industry: Information Technology, Software, Cyber Security
  • Stage:Seed, Series A
  • Geography: Israel, United States, China

Investor stats

  • Total investments: 65
  • Round size: Seed $1.5M–$15M; Series A $1M–$17M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • CartiHeal — Target improved outcomes in the treatment of knee cartilage and osteochondral defects with a porous, biocompatible and biodegradable off-the-shelf implant.
  • Brainsgate — BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on treatment of acute ischemic stroke. Building on its technology, the Company has developedthe ISS, based on a miniature electrode implanted at the roof of the mouth in a bed side, minimally invasive, local anesthesia procedure comparable to dental treatment. In 2008, the company completed ImPACT-1, a pilot clinical trial for acute ischemic stroke with promising results. In 2011 the Company completed a 300 patients RCT pivotal trial that further substantiated the safety and efficacy of its treatment for acute ischemic stroke patients. BrainsGate is currently running the ImpACT-24b, a multi-national, randomized, double-blind, sham-controlled pivotal study to assess the safety and efficacy of its treatment for stroke patients in a 24-hour window.
  • Raven.io — Secure apps with our Runtime Protection Platform. De-prioritize 99% of vulnerabilities with runtime reachability and prevent exploits, zero-days and supply chain attacks with intelligent, library-level policies.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Arkin Holdings
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical startups

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 31
  • Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $270M in 2021

Portfolio highlights

  • Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Show all investments...

Shalom Equity Fund
VC Fund · 2 investments in Israel Medical startups

Shalom Equity Fund

Show more...

Investment focus

  • Industry: Medical, Sensor, Health Care
  • Stage:Seed
  • Geography: Israel

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GeneGrafts — GeneGrafts Ltd. is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias.They have developed a noveltechnology platform based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of target organ are modulated in a predetermined way. This technology is designed for treatment of neurological disorders and cardiac arrhythmias.
  • VisionSense — Visionsense develops novel visualization solutions that bring natural stereoscopic sight to minimally invasive surgery (MIS). With advanced sensor technology and proprietary software, the Visionsense system delivers depth perception, 3D-HD resolution images and maneuvering flexibility through the smallest access diameters. Existing MinimallyInvasive Surgery (MIS) vision solutions provide 2D (monocular) images that lack depth perception. This restricts the surgeon’s perspective limiting the ability to perform advanced MIS procedures. With stereovision capabilities, surgeons gain enhanced tissue understanding, improved hand eye coordination and the confidence to use advanced (articulating) surgical tools.
Show all investments...

SCP Vitalife Partners
VC Fund · Wayne, Pennsylvania, United States · 2 investments in Israel Medical startups

SCP Vitalife is a Life Sciences Fundformed by SCP Partners , a U.S.-based investment organization with over $900 million in venture funds under management, and Vitalife , an experienced venture firm investing primarily in Israeli medical technology companies. The SCP Vitalife team includes investment professionals with prior experiences as seniorexecutives, clinical practitioners and venture capitalists.Their focus is on early to mid-stage life science technologies and services, with a concentration on therapeutic medical devices.They will continue to follow the successful formula of their predecessor fund, Vitalife Life Sciences Fund, offering their portfolio companies hands-on strategic assistance in planning, operations and finance. From their investment experience they have developed extensive networks to access capital, recruit management and facilitate favorable strategic alliances.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series C, Series D
  • Geography: Israel, United States

Investor stats

  • Total investments: 12
  • Round size: Series C $10M–$25M; Series D $1.2M–$43M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • MST Medical Surgery Technologies — Medical Surgery Technologies (MST) was founded in 2005 by Ziv Tamir and Moti Sholev, entrepreneurs with extensive experience in medical devices. MST leads the field of surgical analytics with its core image analytics technology designed to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery(MRCAS).  The company's core technology is a software-based image analytics information platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics. The platform is positioned to enable the operating room of the future through real-time image analytics, connectivity and automation, providing value-added functionality for surgeon, provider and patient. MST’s initial offering is AutoLap™, the only robotic image-guided laparoscope positioning system. Powered by MST’s image-analysis software, AutoLap™ interacts with the surgeon’s movements in the surgical cavity, guiding the robotic laparoscope positioner in real time, offering the surgeon full and natural control of the surgical procedure and an optimal field of view.
  • Ivenix — Bring the power of guided workflows, adaptive fluid delivery, and complete secondary delivery with an Ivenix IV Infusion System. Explore now.
  • Lifeward — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.
Show all investments...

Vertex Ventures
VC Fund · Palo Alto, California, United States · 2 investments in Israel Medical startups

Vertex Ventures US is an early stage VC that backs fearless founders building a smarter digital economy through B2B software.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 444
  • Round size: Series A $3M–$35M; Series B $6M–$48M; Series C $9.3M–$100M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Hotelogix — Best Hotel Management Software: Hotelogix that streamlines Front Desk, Bookings, & Reporting in a single cloud hotel software trusted by 25,000+ hotels globally.
  • Flutura — Accenture discusses how to maximize business potential with Accenture's Industrial Intelligence Suite. Read more.
  • Ace Turtle Omni Pvt Ltd — We help retail businesses in India, Singapore & Malaysia convert multichannel sales & marketing strategies to omnichannel on marketplaces & own websites
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 2 investments in Israel Medical startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 653
  • Round size: Series A $10M–$150M; Series B $24M–$150M; Series C $18M–$183M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • CardiAQ Valve Technologies — CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).
  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Acceleron Pharma — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Show all investments...

fresh.fund
VC Fund · Jerusalem, Yerushalayim, Israel · 2 investments in Israel Medical startups, 7 in the past 12 months

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, Norway

Investor stats

  • Total investments: 44
  • Round size: Seed $1.6M–$10M; Pre-Seed $300k–$6M; Series A $11M–$21M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Kimba — Kimba is the first sleep system that reads your body and responds to it silently and automatically every night, using the only sensory pathway that can reach a sleeping brain. Reserve your Kimba today!
  • CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
  • Shifters AI — Shifters builds autonomous robotic teams for dangerous ground missions.
Show all investments...

LionBird
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

LionBird is a Tel Aviv- and Chicago-based venture capital firm investing in early-stage software companies operating in the healthcare, commerce, and enterprise sectors. Founded in 2012, LionBird has developed an investment strategy around early-stage startups that leverages online technology to re-imagine traditional offline business processes andmodels.

Show more...

Investment focus

  • Industry: Health Care, Software, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, India

Investor stats

  • Total investments: 74
  • Round size: Seed $1.3M–$17M; Series A $3.5M–$19M; Series B $6.5M–$40M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $85M in 2022

Portfolio highlights

  • FlipOS — Stoa partners with real estate investors who buy, renovate and sell single family homes. We fund their deals, create the renovation scope and purchase the properties from them at the end of the renovation. Our proprietary technology allows us to significantly shorten the process without compromising the quality of service.
  • Jimini Health — Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.
  • Rhino Federated Computing — Rhino Federated Computing solves one of the biggest challenges in AI: seamlessly connecting siloed data through federated computing.
Show all investments...

TechWald Holding S.p.A.
VC Fund · Milan, Lombardia, Italy · 2 investments in Israel Medical startups

TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Series A $3.6M–$7.1M; Series B $8.5M–$48M; Series C $9.3M–$60M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
  • RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Show all investments...

DEFTA Partners
VC Fund · San Francisco, California, United States · 2 investments in Israel Medical startups

DEFTA Partners is a venture capital firm focusing on technology. They primarily make seed and first round investments in early stage information technology companies with global opportunities to accelerate growth. DEFTA has offices and partners in the United States, Japan, Israel and the United Kingdom. via: DEFTA Partners

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B
  • Geography: United States, Israel, Japan

Investor stats

  • Total investments: 32
  • Round size: Series A $2.5M–$13M; Series B $6.5M–$47M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $63M in 2019

Portfolio highlights

  • Fortinet — Fortinet secures the largest enterprise, SMB, service provider, and government organizations around the world. Secure your network today and into the future.
  • 1World Online — We believe it's important for everyone to know what people really think about today's social issues
  • Endogena — Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders.The company implements innovation in the field of regenerative medicine. Their sciencecombines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases.
Show all investments...

Grove Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups, 9 in the past 12 months

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners with seed and early-stage founders

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 73
  • Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $185M in 2022

Portfolio highlights

  • LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
  • Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
  • FormX — California's trusted sustainable builders. FormX delivers fully customized single-family homes, ADUs, and backyard offices built faster with component-based modular construction.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
ZORA Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical startups

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Food and Beverage
  • Stage:Seed, Series A, Convertible Note
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 16
  • Round size: Seed $1M–$8.6M; Series A $4M–$8.1M
  • Lead/follow: 6% lead, 94% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
  • WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
  • Earth Force Technologies — Earth Force is a Vegetation Management System platform.
Show all investments...

Hanaco Venture Capital
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Hanaco Venture Capital is a technology company with visionary and passionate entrepreneurs. Hanaco was founded by Alon Lifshitz, Lior Prosor, and Pasha Romanovski in 2017 and is headquartered in Tel Aviv, Israel.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Series A, Seed, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 101
  • Round size: Seed $3M–$11M; Series A $6M–$35M; Series B $15M–$56M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Milestone — Milestone ensures your GenAI tools are fully integrated, optimized, and aligned with your business goals, driving measurable ROI and sustained innovation.
  • EasySend — Bring your enterprise up to speed, so you can increase your revenue and cut costs faster with EasySend.
  • Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
Show all investments...

Mithril Capital Management
VC Fund · San Francisco, California, United States · 2 investments in Israel Medical startups

Mithril is a family of long-term venture capital funds agnostic to sector and geography. We invest and partner with teams who use technology to build valuable and lasting businesses, often in industries long overdue for change.

Show more...

Investment focus

  • Industry: Software, Health Care, Enterprise Software
  • Stage:Series C, Series B, Series D
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 68
  • Round size: Series B $10M–$150M; Series C $15M–$142M; Series D $15M–$300M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $850M in 2017

Portfolio highlights

  • Neocis — Yomi, a dental robot, is the next generation in implant surgery that can give patients a better experience, expand your offerings and boost your efficiency
  • GreyOrange — Learn about GreyOrange 2026 from GreyOrange, where AI-driven warehouse and retail store solutions reduce costs, increase accuracy and power omnichannel success.
  • Helion Energy — Helion is building the world's first fusion power plant to deliver clean, reliable, and abundant electricity to the grid.
Show all investments...

HealthpointCapital
VC Fund · New York, New York, United States · 2 investments in Israel Medical startups

HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Manufacturing
  • Stage:Series B, Series C
  • Geography: Israel, United States

Investor stats

  • Total investments: 7
  • Round size: Series B $5M–$13M; Series C $12M–$15M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
  • OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!
Show all investments...

Israel Healthcare Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Israel HealthCare Ventures (IHCV) - a leading Israeli life sciences venture fund - was founded at the end of the year 2000. The fund is focused on providing funds (capital) to Israeli and Israeli-related companies in the fields of medical devices, pharmaceuticals, biotechnology, nanotechnology and medical-related IT.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series D, Series F
  • Geography: Israel, United States

Investor stats

  • Total investments: 8
  • Round size: Series D $1.2M–$16M; Series F $19M–$40M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • OrSense — OrSense is a medical device company that develops and commercializes patient monitoring solutions for non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose and other blood parameters. OrSense's NBM-200MP monitors and displays oxygen saturation of Hb (SpO2), low signal oximetry, SpO2, pulse rate, plethysmogram andhemoglobin, all non-invasively and continuously. The system is designed for use in hospitals including operating and recovery rooms and intensive care units as well as in outpatient sites and emergency services. OrSense's non-invasive hemoglobin/hematocrit monitor was granted the CE approval and was tested on over 4,000 patients and donors at 15 sites in the U.S. and Europe. The Company's products are based on its proprietary Occlusion Spectroscopy technology, which overcomes key obstacles that hinder the performance of competing approaches.
  • Gamida Cell — Gamida Cell is dedicated to making a significant difference in the clinical practice of modern medicine by first creating, then tapping the regenerative power of therapeutic stem cells. Gamida Cell is a leader in the development of stem cell therapy technologies and products. The therapies are based on expanded populations of cord blood stem cells,for the treatment of illnesses with significant unmet clinical needs such as blood cancers, autoimmune and metabolic diseases as well as neutropenia.
  • Lifeward — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.
Show all investments...

Eclipse
VC Fund · Palo Alto, California, United States · 2 investments in Israel Medical startups

Palo Alto based Eclipse Ventures partners with entrepreneurs boldly transforming the essential industries that define and propel economies. Learn more.

Show more...

Investment focus

  • Industry: Software, Robotics, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 221
  • Round size: Seed $2.3M–$24M; Series A $9.1M–$55M; Series B $15M–$100M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $510M in 2023

Portfolio highlights

  • Kindred AI — Kindred's mission is to build machines with human-like intelligence. Since its founding in 2014, Kindred has been exploring and engineering systems that enable robots to interact with the physical world, fulfilling the goal of bringing humans and intelligent machines together to solve real-world problems. Kindred has built an AI platformthat integrates vision, grasping and placement to create autonomous solutions for complex commercial problems. With increased labor complexities in e-commerce fulfillment centers, Kindred developed a flagship product, SORT, to help retailers stay competitive. Kindred smart piece-picking SORT robots tackle a labor intensive part of the supply chain, which is Putwall Sortation, completing the manual task to pick and place items into separate customer orders. Kindred robots are currently in commercial use at e-commerce leaders including Gap, Inc., Carter’s and other global retailers. The Kindred SORT robots work alongside warehouse staff to quickly and accurately sort items into individual customer orders. Kindred has offices in San Francisco & Toronto.
  • Cerebras Systems — Cerebras is the go-to platform for fast and effortless AI training. Learn more at cerebras.ai.
  • Flex Logix Technologies — Flex Logix charges a license fee for the delivery of the design files and tools, an annual license fee for the ongoing use of the EFLX Compiler for reprogramming, and a royalty. The company was founded in 2014 and is based in Mountain View, California.
Show all investments...

Mindset Ventures
VC Fund · São Paulo, Sao Paulo, Brazil · 2 investments in Israel Medical startups

Mindset Ventures is an early-stage VC firm that supports entrepreneurs in their growth and international expansion. The firm targets B2B startups technology applied to Agriculture, Financial Services, Healthcare, Cybersecurity, Education, and Enterprise Software industry. It was founded in 2016 and headquartered in Sao Paulo, Brazil.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Series A, Seed, Series B
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 108
  • Round size: Seed $2.3M–$14M; Series A $6M–$30M; Series B $6.8M–$35M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • FunnelBeam — FunnelBeam is a AI-driven Account-Based Sales Build Your Unique Sales Machine Model. Find Your Top Prospects. Get Deep Account & Prospect Level Data, Enrichment & Analytics. Personalize Your Messages. Convert Faster.
  • Metric Insights — Metric Insights is an operator of a business intelligence platform used to empower businesses to effectively cut through data clutter. It helps to track metrics from business intelligence tools, big data, and SaaS applications, and uncovers anomalies and notifies users of significant changes in data that requires their attention that enable clientsto benefit from intelligent data-driven decisions. It was founded in 2010 and headquartered in San Francisco, California.
  • ChopValue Manufacturing — Creating beautiful, high-performance engineered products made entirely from recycled chopsticks. We offer green franchising opportunities so you can make a positive difference in your community. Let's work towards a circular economy, one chopstick at a time.
Show all investments...

Qure Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical startups

Qure Ventures is venture capital firm under OurCrowd. Qure is led by successful digital health veterans with vast experience founding, growing, and exiting companies over the last 20+ years.Qure has established strategic partnerships with key stakeholders in consumer, provider, payer, as well as pharma domains - providing fast track access tomarket and clinical trial opportunities for portfolio companies.Qure is Israel's first exclusively focused digital health fund. The fund focuses predominantly on startups located in Israel, home to world's leading tech + digital health ecosystem. OurCrowd's global network, investment leadership and in-house medical expertise provide Qure with unparalleled deal access and robust diligence.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel

Investor stats

  • Total investments: 8
  • Round size: Series A $11M–$20M; Series B $20M–$20M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • CoreMap — CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
  • Sweetch — Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions. Its hyper-personalized precision engagement platform enables health ecosystem players to build continuous relationships and engage with every individual patient, at scale.
  • Carevive Systems — Powered by real world patient experience data, Carevive builds cancer care management tools that improve patient quality of life and survival outcomes.
Show all investments...

Lightspeed Venture Partners
VC Fund · Menlo Park, California, United States · 2 investments in Israel Medical startups

Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, India, Israel

Investor stats

  • Total investments: 2032
  • Round size: Seed $2.5M–$30M; Series A $7.5M–$90M; Series B $15M–$125M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $2.4B in 2022

Portfolio highlights

  • Tennr — Tennr is a custom AI assistant that accelerates research, answers complex questions, and generates custom reports.
  • Aquantia — At Aquantia, all three elements are present in abundance. Aquantia benefits from team members with a depth of diverse technology development expertise, signal processing innovation and an adherence to lean and agile management practices. Their engineers were at the forefront ofthe Fast Ethernet and Gigabit Ethernet product deployments, and areamong the best in production silicon design.Meet their leadership team, or the board and investors to see their guidance, financial backing and the company they've built.
  • Eightfold AI — Eightfold AI provides the most comprehensive AI recruiting and talent management solutions in the market. We make it easy for businesses to find, screen, and hire the best talent.
Show all investments...

GlenRock Israel
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical startups

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Show more...

Investment focus

  • Industry: Software, Health Care, Cyber Security
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 35
  • Round size: Seed $1M–$9M; Series A $1.5M–$9M; Series B $100k–$30M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
  • MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
  • Quris — Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Show all investments...

Medical VC funding in Israel at a glance

Stats across 476 deals from 522 investors.

522
investors
in Israel Medical startups
476
deals
in Israel Medical startups
$5.6M
median round
in Israel Medical startups
38%
lead investors
lead at least one round
17%
Seed
most common funding stage

Access all 522 VC funds in Israel Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 522 VC funds investing in Israel Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists